Fresenius Medical Care Q2 2026 Earnings Call Transcript

Fresenius Medical Care (NYSE: FMS ) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Fresenius Medical Care reported a 23% increase in operating income, driven by strong organic revenue growth and improvements in profitability, alongside the FME 25+ transformation program which delivered €67 million in savings. The company completed a €1 billion share buyback program ahead of schedule and initiated a second €1 billion program, maintaining a net leverage ratio of 2.6 times. U.S. same market treatment growth declined by 0.9% due to o...